SEARCH

SEARCH BY CITATION

References

  • 1
    Segal BH . Aspergillosis . N Engl J Med 2009 ; 360 : 18701884 .
  • 2
    Herbrecht R , Denning DW , Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis . N Engl J Med 2002 ; 347 : 408415 .
  • 3
    Cornely OA , Maertens J , Bresnik M et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial) . Clin Infect Dis 2007 ; 44 : 12891297 .
  • 4
    Ascioglu S , Rex JH , de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus . Clin Infect Dis 2002 ; 34 : 714 .
  • 5
    De Pauw B , Walsh TJ , Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group . Clin Infect Dis 2008 ; 46 : 18131821 .
  • 6
    Chamilos G , Luna M , Lewis RE et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003) . Haematologica 2006 ; 91 : 986989 .
  • 7
    Hachem R , Sumoza D , Hanna H , Girgawy E , Munsell M , Raad I . Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised? Cancer 2006 ; 106 : 15811586 .
  • 8
    Sinko J , Csomor J , Nikolova R et al. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey . Transpl Infect Dis 2008 ; 10 : 106109 .
  • 9
    Subira M , Martino R , Rovira M , Vazquez L , Serrano D , De La Camara R . Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis . Ann Hematol 2003 ; 82 : 8082 .
  • 10
    Nucci M , Nouér SA , Grazziutti M , Kumar NS , Barlogie B , Anaissie E . Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies . Clin Infect Dis 2010 ; 51 : 12731280 .
  • 11
    Girmenia C , Micozzi A , Gentile G et al. Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study . J Clin Oncol 2010 ; 28 : 667674 .
  • 12
    Segal BH , Herbrecht R , Stevens DA et al. Defining responses to therapyand study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensuscriteria . Clin Infect Dis 2008 ; 47 : 674683 .
  • 13
    Viscoli C , Herbrecht R , Akan H et al. An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients . J Antimicrob Chemother 2009 ; 64 : 12741281 .
  • 14
    Freifeld AG , Bow EJ , Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america . Clin Infect Dis 2011 ; 52 : e56e93 .
  • 15
    Maertens J , Marchetti O , Herbrecht R et al. , . European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 Update. Bone Marrow Transplant . Bone Marrow Transplant 2011 ; 46 : 708718 .